Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients

Clinical trial NCT00044525 · COMPLETED

Trial details

NCT number: NCT00044525
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Breast Cancer, Metastatic

Start date: 2002-04-01
Primary completion: 2004-02-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.